2VZ Stock Chart & Stats
€37.40
€1.42(4.60%)
At close: 4:00 PM EST
€37.40
€1.42(4.60%)
Day’s Range― - ―
52-Week Range€27.36 - €42.56
Previous CloseN/A
Volume200.00
Average Volume (3M)73.00
Market Cap
€10.42B
Enterprise Value€12.37B
Total Cash (Recent Filing)€328.00M
Total Debt (Recent Filing)€271.00M
Price to Earnings (P/E)41.4
Beta0.62
Next Earnings
Jul 30, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.08
Shares Outstanding266,762,100
10 Day Avg. Volume66
30 Day Avg. Volume73
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)3.31
Price to Sales (P/S)2.48
P/FCF Ratio39.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€46.65Price Target Upside24.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)1.13
Revenue Forecast (FY)€3.44B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthVery low leverage (TTM debt-to-equity ~0.05) and rising ROE (~10.8% TTM from ~7.2% in 2023) provide durable financial flexibility. This supports bidding on government programs, funds capex/working capital needs internally, and reduces refinancing risk through budget cycles.
Improving Cash GenerationSustained operating cash flow and strong FCF (TTM operating cash flow $438M, FCF $301M) convert earnings into spendable cash, enabling dividends, buybacks and reinvestment. Robust cash conversion underpins long-term program support and reduces reliance on external financing.
Record Backlog & Raised GuidanceManagement raised full‑year 2026 guidance (revenue $3.9B–$3.975B) while funded backlog reached company records and book-to-bill stayed ≥1x for 17 quarters. That backlog and recurring book-to-bill consistency deliver multi-quarter revenue visibility and de-risk medium-term cashflows.
Bears Say
Volatile Cash Conversion HistoryHistorical swings—including negative free cash flow in 2022 and episodic margin volatility—indicate cash conversion can be lumpy. That structural variability can complicate funding of program ramps, constrain discretionary returns during weak years, and increase planning risk.
Reliance On Government BudgetsA substantial share of revenue depends on U.S. government appropriations and program funding. Congressional timing or priority shifts can delay awards or payments, slowing backlog conversion and pressuring working capital and revenue realization despite strong underlying demand.
Ramping Capex And Working Capital NeedsManagement expects capex to rise to ~5% of sales and to deploy higher working capital to support growth. These structural increases will temper free cash flow conversion and require sustained operating performance to preserve cash returns or may necessitate incremental funding during peaks.
2VZ FAQ
What was Leonardo Drs, Inc.’s price range in the past 12 months?
Leonardo Drs, Inc. lowest stock price was €27.36 and its highest was €42.56 in the past 12 months.
What is Leonardo Drs, Inc.’s market cap?
Leonardo Drs, Inc.’s market cap is €10.42B.
When is Leonardo Drs, Inc.’s upcoming earnings report date?
Leonardo Drs, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 20 days.
How were Leonardo Drs, Inc.’s earnings last quarter?
Leonardo Drs, Inc. released its earnings results on May 05, 2026. The company reported €0.227 earnings per share for the quarter, beating the consensus estimate of €0.179 by €0.048.
Is Leonardo Drs, Inc. overvalued?
According to Wall Street analysts Leonardo Drs, Inc.’s price is currently Undervalued.
Does Leonardo Drs, Inc. pay dividends?
Leonardo Drs, Inc. does not currently pay dividends.
What is Leonardo Drs, Inc.’s EPS estimate?
Leonardo Drs, Inc.’s EPS estimate is 0.24.
How many shares outstanding does Leonardo Drs, Inc. have?
Leonardo Drs, Inc. has 266,762,100 shares outstanding.
What happened to Leonardo Drs, Inc.’s price movement after its last earnings report?
Leonardo Drs, Inc. reported an EPS of €0.227 in its last earnings report, beating expectations of €0.179. Following the earnings report the stock price went up 3.953%.
Which hedge fund is a major shareholder of Leonardo Drs, Inc.?
Currently, no hedge funds are holding shares in DE:2VZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Leonardo Drs Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€46.65 (24.74% Upside)
€46.65 (24.74% Upside)
Blogger Sentiment
Bullish
DE:2VZ Sentiment 70%
Sector Average 64%
Sector Average 64%
Insider Transactions
Bought Shares
Worth €480.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.07%
12-Months-Change
Fundamentals
Return on Equity
10.79%
Trailing 12-Months
Asset Growth
2.81%
Trailing 12-Months
Company Description
Leonardo Drs, Inc.
Established in Arlington, Virginia, in 1969, Leonardo DRS, Inc. is a leading supplier of advanced defense products and technologies. The company's diverse portfolio addresses military requirements across various environments, including land, air, sea, space, and cybersecurity, with additional applications in the commercial sector. Its operations are organized into two primary divisions: Advanced Sensing and Computing, and Integrated Mission Systems. DRS provides sophisticated sensing solutions, such as infrared systems for threat identification and improving situational awareness, alongside uncooled infrared technologies and systems designed to mitigate brownout conditions. Their electronic warfare (EW) capabilities encompass airborne, vehicle-mounted, and soldier-borne systems, supported by specialized EW software, training tools, and intelligence services. Furthermore, Leonardo DRS develops essential computing systems for military platforms like ground vehicles, ships, and submarines. These offerings include robust network and data distribution applications, integrated sensor systems, and resilient networked computing infrastructure. The company also specializes in force protection, delivering solutions for counter-unmanned aerial systems (C-UAS), short-range air defense, and active protection systems. Additionally, DRS is a key provider of power management and propulsion technologies, offering systems for power control, distribution, conversion, and propulsion—including hybrid electric drive systems, energy storage solutions, gas turbine packages, nuclear instrumentation and controls, and thermal management and refrigeration equipment. Leonardo DRS serves a broad client base, which includes the U.S. military, major aerospace and defense contractors, government intelligence agencies, and international armed forces.
2VZ Company Deck
2VZ Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong financial quarter with clear operational momentum: revenue and profitability grew meaningfully (revenue +6%, adjusted EBITDA +28%, margin +210 bps), backlog hit record levels, and management raised full-year guidance across revenue, adjusted EBITDA and adjusted EPS. Positives from program execution, favorable material timing, contract wins (including a $533M DAIRCM IDIQ) and product innovation outweigh the main negatives—seasonal free cash outflow, short-term variability tied to timing of receipts and program execution, and budgetary uncertainty from Congress. Management is investing to capture demand, which pressures near-term cash conversion but supports growth and margin expansion.View all DE:2VZ earnings summaries2VZ Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€46.65
▲(24.74% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Options Prices
Currently, No data available
---








